New daily pill aims to ease diabetic eye swelling
NCT ID NCT07459829
First seen Apr 07, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study tests an experimental daily pill (CU06-1004) for people with diabetic macular edema, a condition that causes vision loss from fluid buildup in the eye. About 156 adults will take either a low dose, high dose, or a placebo for 24 weeks. The main goal is to see if the pill improves vision and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.